[Federal Register Volume 70, Number 143 (Wednesday, July 27, 2005)]
[Notices]
[Page 43401]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-14799]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Intent to Grant Exclusive Patent License; Sensera, Inc.

AGENCY: Department of the Navy, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to Sensera, Inc., a revocable, nonassignable, exclusive 
license, to practice in the field of in vitro diagnosis of human 
disease(s) and determination of disease indicators for the subfields of 
Point of Care Rapid Diagnosis of Cardiac Infarction Indictors such as 
cardiac Troponin I, cardiac Troponin T, Myoglobin, and Creatine Kinase-
Myocardial Band; Point of Care Rapid Diagnosis of Stroke Indicators; 
Point of Care Rapid Diagnosis of Cancer Markers such as those for 
breast, prostate, colorectal, and cervical cancer and Point of Care 
Rapid Diagnosis of Infectious Disease such as Sexually Transmitted 
diseases, Hepatitis, TB, tropical traveler's diseases, Lyme disease, 
toxoplasmosis, cryptosporidium in drinking water, Group A strep, 
antibiotic resistant staph and strep in the United States and certain 
foreign countries, the Government-owned inventions described in U.S. 
Patent No. 5,372,930: Sensors for Ultra-Low Concentration Molecular 
Recognition, Navy Case No. 73,568//U.S. Patent No. 5,807,758: Chemical 
and Biological Sensor Using an Ultra-Sensitive Force Transducer, Navy 
Case No. 76,628//U.S. Patent No. 6,180,418: Force Discrimination Assay, 
Navy Case No. 78,183//U.S. Patent No. 6,676,904: Nanoporous Membrane 
Immunosensor, Navy Case No. 80,068.

DATES: Anyone wishing to object to the grant of this license must file 
written objections along with supporting evidence, if any, not later 
than August 11, 2005.

ADDRESSES: Written objections are to be filed with the Naval Research 
Laboratory, Code 1004, 455 Overlook Avenue, SW., Washington, DC 20375-
5320.

FOR FURTHER INFORMATION CONTACT: Ms. Jane Kuhl, Head, Technology 
Transfer Office, NRL Code 1004, 4555 Overlook Avenue, SW., Washington, 
DC 20375-5320, telephone 202-767-3083. Due to U.S. Postal delays, 
please fax 202-404-7920, E-Mail: [email protected] or use 
courier delivery to expedite response.
    (Authority: 35 U.S.C. 207, 37 CFR part 404.)

    Dated: July 21, 2005.
I.C. LeMoyne, Jr.,
Lieutenant, Judge Advocate General's Corps, U.S. Navy, Alternate 
Federal Register Liaison Officer.
[FR Doc. 05-14799 Filed 7-26-05; 8:45 am]
BILLING CODE 3810-FF-M